Amphenol has achieved record fourth-quarter revenue of $6.44 billion, up 49.1% year-over-year and exceeding analysts' expectations by 3.3%. Despite this strong performance, its stock has dropped approximately 10.6% post-report, raising red flags about its valuation, which is overvalued by 24.7% with a P/E ratio of 42.04. The company also confronts challenges from integration risks and high leverage following recent acquisitions.